WealthPLAN Partners LLC lessened its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 8.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,139 shares of the company’s stock after selling 191 shares during the period. WealthPLAN Partners LLC’s holdings in Procter & Gamble were worth $341,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares during the period. Northern Trust Corp lifted its holdings in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after acquiring an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after acquiring an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Trading Up 1.4%
Shares of NYSE PG opened at $149.50 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a 52-week low of $146.96 and a 52-week high of $180.43. The firm has a 50 day moving average price of $154.96 and a two-hundred day moving average price of $158.97. The stock has a market cap of $349.90 billion, a P/E ratio of 22.96, a price-to-earnings-growth ratio of 3.91 and a beta of 0.36.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio is 64.98%.
Analysts Set New Price Targets
PG has been the subject of several research reports. BNP Paribas reissued an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reissued an “in-line” rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Barclays dropped their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. JPMorgan Chase & Co. dropped their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research note on Friday, October 10th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.
Check Out Our Latest Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other news, CFO Andre Schulten sold 4,252 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer directly owned 53,992 shares in the company, valued at $8,219,202.16. This represents a 7.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the sale, the chief executive officer owned 319,932 shares of the company’s stock, valued at approximately $48,703,248.36. This trade represents a 3.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 over the last 90 days. 0.20% of the stock is owned by company insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- What Is WallStreetBets and What Stocks Are They Targeting?
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- Election Stocks: How Elections Affect the Stock Market
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.